BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2015264.pdf
Reference67 articles.
1. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E et al. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 2000; 19: 617–623.
2. Verdecia MA, Huang Hk, Dutil E, Kaiser DA, Hunter T, Noel JP . Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Mol Biol 2000; 7: 602–608.
3. Morgillo F, Woo JK, Kim ES, Hong WK, Lee HY . Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib. Cancer Res 2006; 66: 10100–10111.
4. Tran J, Master Z, Yu JL, Rak J, Dumont DJ, Kerbel RS . A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci 2002; 99: 4349–4354.
5. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C et al. Analysis of human transcriptomes. Nat Genet 1999; 23: 387–388.
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Defining neuroblastoma: from origin to precision medicine;Neuro-Oncology;2024-08-05
2. Survivin as a Therapeutic Target for the Treatment of Human Cancer;Cancers;2024-04-27
3. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor;eLife;2024-03-15
4. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor;2024-02-20
5. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma;Head & Neck;2024-02-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3